Scientists, entrepreneurs, and journalists have reached for colorful metaphors to explain CRISPR-Cas9 gene editing technology. Many are really, really bad.
The FDA this week said it’s illegal to sell kits that allow do-it-yourself editing of human genes. But it’s unclear which products would cross that line.
The Food and Drug Administration has approved a promising new treatment called CAR-T for a particularly deadly form of cancer.
J uno Therapeutics is abandoning a cancer therapy that once looked like a revolutionary advance, reacting to a rash of patient deaths that made the customized treatment too risky to push forward. The company’s decision changes the landscape in a blockbuster race to commercialize the first CAR-T technology, a promising new approach to cancer in which …
The US patent office ruled Wednesday that hotly disputed patents on the revolutionary genome-editing technology CRISPR-Cas9 belong to the Broad Institute.
There’s a whole lot of hype around precision medicine. Can it really revolutionize treatments? Dr. Eric Topol is a true believer.